Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
8.00
+0.47 (6.24%)
At close: Dec 5, 2025, 4:00 PM EST
8.07
+0.07 (0.88%)
After-hours: Dec 5, 2025, 6:59 PM EST
Cross Country Healthcare Revenue
Cross Country Healthcare had revenue of $250.05M in the quarter ending September 30, 2025, a decrease of -20.65%. This brings the company's revenue in the last twelve months to $1.13B, down -22.14% year-over-year. In the year 2024, Cross Country Healthcare had annual revenue of $1.34B, down -33.46%.
Revenue (ttm)
$1.13B
Revenue Growth
-22.14%
P/S Ratio
0.23
Revenue / Employee
$117,384
Employees
9,605
Market Cap
262.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.34B | -675.72M | -33.46% |
| Dec 31, 2023 | 2.02B | -783.65M | -27.95% |
| Dec 31, 2022 | 2.80B | 1.13B | 67.20% |
| Dec 31, 2021 | 1.68B | 840.24M | 100.46% |
| Dec 31, 2020 | 836.42M | 14.19M | 1.73% |
| Dec 31, 2019 | 822.22M | 5.74M | 0.70% |
| Dec 31, 2018 | 816.48M | -48.56M | -5.61% |
| Dec 31, 2017 | 865.05M | 31.51M | 3.78% |
| Dec 31, 2016 | 833.54M | 66.12M | 8.62% |
| Dec 31, 2015 | 767.42M | 149.60M | 24.21% |
| Dec 31, 2014 | 617.83M | 179.51M | 40.96% |
| Dec 31, 2013 | 438.31M | -4.32M | -0.98% |
| Dec 31, 2012 | 442.64M | 3.26M | 0.74% |
| Dec 31, 2011 | 439.38M | 32.77M | 8.06% |
| Dec 31, 2010 | 406.60M | -171.63M | -29.68% |
| Dec 31, 2009 | 578.24M | -156.01M | -21.25% |
| Dec 31, 2008 | 734.25M | 15.97M | 2.22% |
| Dec 31, 2007 | 718.27M | 63.12M | 9.63% |
| Dec 31, 2006 | 655.15M | 9.76M | 1.51% |
| Dec 31, 2005 | 645.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CCRN News
- 1 day ago - Cross Country Healthcare Merger Agreement with Aya Healthcare Terminated - Business Wire
- 23 days ago - Cross Country Healthcare Announces Third Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Cross Country Marketing Team Wins Global OnCon Icon Award; Named No. 1 in the Nation - Business Wire
- 4 months ago - CCRN Earnings Drop 19% - The Motley Fool
- 4 months ago - Cross Country Healthcare Announces Second Quarter 2025 Financial Results - Business Wire
- 5 months ago - Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade) - Seeking Alpha
- 7 months ago - Cross Country Healthcare Announces First Quarter 2025 Financial Results - Business Wire
- 7 months ago - Nursing in 2025: No Relief in Sight as Burnout, Stress & Short Staffing Persist - Business Wire